Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04996160
Title Palbociclib in Combination With Chemotherapy in Pediatric Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia (RELPALL2)
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Stanford University
Indications

acute lymphoblastic leukemia

Therapies

Bortezomib + Dexamethasone + Doxorubicin + Palbociclib

Age Groups: adult | child
Covered Countries USA

Facility Status City State Zip Country Details
Lucile Packard Children's Hospital Stanford Recruiting Stanford California 94304 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field